Document:

Employment Agreement

 Exhibit 4.13 

 
 

 
  

	
	 Employment

Agreement

	
	  

	
	 Prima Biomed Limited
 ACN 009 237 889

	
	Ginny Raymond

  

					
		 	 McCabe Terrill Lawyers Pty Limited
 ACN 122 850 033
  
 130 Elizabeth Street (Level 14)
 Sydney NSW 2000

 
 GPO Box 235 Sydney NSW 2001

DX 145 Sydney
	  	 T +61 2 9261 1211
  

F +61 2 9261 2336
  

W www.mccabeterrill.com.au

 Table of Contents 

 

							
			
	 1.
	 	Definition and Interpretation	  	 	3	  
			
	 2.
	 	Commencement and pre-conditions to employment	  	 	5	  
			
	 3.
	 	Position and duties	  	 	6	  
			
	 4.
	 	Hours of Work	  	 	7	  
			
	 5.
	 	Remuneration	  	 	7	  
			
	 6.
	 	Leave Entitlements	  	 	8	  
			
	 7.
	 	Conflicts of Interest	  	 	9	  
			
	 8.
	 	Confidential Information	  	 	9	  
			
	 9.
	 	Intellectual Property	  	 	10	  
			
	 10.
	 	Restraint	  	 	10	  
			
	 11.
	 	Termination	  	 	12	  
			
	 12.
	 	Personal information	  	 	13	  
			
	 13.
	 	General	  	 	13	  
		
	 Schedule 1
	  	 	16	  
		
	 Schedule 2
	  	 	17	  
		
	 Schedule 3
	  			

  

  
 2. 

 Dated 
 Parties 
  

			
	 Prima Biomed Limited
	  	 ACN 009 237 889

	 Address:
	  	 Suite 1, 1233 High Street, ARMADALE, VIC, AUSTRALIA, 3143

	 Facsimile:
	  	 + 61 3 9822 7735

	 Attention:
	  	 Martin Rogers

	 (Company)
	  	
		
	 Ginny Raymond
	  	
	 Address:
	  	 59 Whippoorwill Crossing

		  	 Armonk, NY 10504 USA

	 Facsimile:
	  	 +1 914 273 9153

	 (Employee)
	  	

 Background 
  

	A	The Company operates the Business. 

  

	B	The Company has agreed to employ the Employee, and the Employee has agreed to serve the Company as an employee, on the terms and conditions of this agreement.

  

	1.	 Definition and Interpretation 

  

	1.1	 Definitions: 

 In this agreement, unless the contrary intention appears, the following words have the following meanings: 
  

			
	Term:	  	Definition:
		
	 Business
	  	the business carried on by Group, being the business of researching, developing and commercialising a portfolio of biotechnology products related to the therapeutic area of
cancer, and such other business as the Company advises the Employee of in writing during the course of the Employee’s employment.
		
	 Claim
	  	in relation to any person, a damage, loss, cost, expense or liability incurred by the person or a claim, action, proceeding or demand made against the person, however arising and
whether present or future, fixed or unascertained, actual or contingent.
		
	 Commencement Date
	  	the date specified in item 1 of Schedule 1.
		
	 Confidential Information
	  	any information, whether in written, electronic or other form, which the Employee has access to during the Employee’s employment with the Company or in the Business,
including:
		
		  	 (a)    information relating to the customers or suppliers of the Group including (without
limitation):

		
		  	 (i)          their contact details;

  
 3. 

			
		  	 (ii)     information relating to expenditure and consumption levels of the Group’s customers or
suppliers; and

		
		  	 (iii)   the prices and costs at which the Group sells products to customers or sources material from
suppliers;

		
		  	 (b)     details of the transactions or affairs of the Group;

		
		  	 (c)     financial information relating to the Group;

		
		  	 (d)     trade secrets;

		
		  	 (e)     business forecasts, strategic plans and projections, operational structure, methodology and
future developments of the Group;

		
		  	 (f)      marketing information relating to the Group, including marketing plans and methodologies,
promotional material and presentations;

		
		  	 (g)     product ingredients, formulae, designs, specifications, ideas, concepts and techniques used or
contemplated to be used in relation to the Business of the Group or relating to any products sold or distributed by the Group;

		
		  	 (h)     information concerning the Group’s employees, contractors or agents;

		
		  	 (i)      technological processes, technology and equipment used or contemplated to be used in
relation to the Business or the Group; and

		
		  	 (j)      any other information or data that the Employee is given or which comes to the
Employee’s knowledge during the course of the employment that the Employee is told is confidential, or that a reasonable person would expect from its nature to be confidential.

		
	 Corporations Act
	  	Corporations Act 2001 (Cth).
		
	 Group
	  	the Company and each of its Related Companies.
		
	 Human Resources Manual
	  	the human resources manual issued by the Company to its employees, as varied from time to time.
		
	 Intellectual Property Rights
	  	all intellectual property rights including current and future registered and unregistered rights in respect of copyright, designs, circuit layouts, trade marks, trade secrets,
know-how, confidential information, patents, inventions and discoveries and all other rights resulting from intellectual activities in the industrial, scientific, literary, commercial or artistic fields of the Company.
		
	 Location
	  	the location specified in item 3 of Schedule 1.

  
 4. 

			
	 Position
	  	the position specified in item 2 of Schedule 1, and any other position to which the Employee is appointed in accordance with this agreement.
		
	 Related Company
	  	has the same meaning given to that term in section 50 of the Corporations Act.
		
	 Remuneration Package
	  	the Employee’s annual remuneration package as specified in clause 5.1, and includes any variations as agreed between the Company and the Employee or as determined by the
Company.

  

	1.2	 Interpretation 

 In this agreement, unless the context otherwise requires: 
  

	 	(a)	the singular includes the plural and vice versa; 

  

	 	(b)	another grammatical form of a defined word or expression has a corresponding meaning; 

 

	 	(c)	a reference to a clause, paragraph or schedule is to a clause or paragraph of or schedule to this agreement and a reference to this agreement includes any schedule or
annexure; 

  

	 	(d)	a reference to a document or instrument, includes the document or instrument as novated, altered, supplemented or replaced from time to time; 

 

	 	(e)	a reference to a party to this agreement, and a reference to a party to a document includes the party’s executors, administrators, successors and permitted assigns
and substitutes; 

  

	 	(f)	a reference to a person includes a natural person, partnership, body corporate, association, governmental or local authority or agency or other entity;

  

	 	(g)	a reference to a statute, ordinance, code or other law includes regulations and other instruments under it and consolidations, amendments, re-enactments or replacements
of any of them; 

  

	 	(h)	the meaning of general words is not limited by specific examples introduced by including, for example or similar expressions; 

 

	 	(i)	a rule of construction does not apply to the disadvantage of a party because the party was responsible for the preparation of this agreement or any part of it; and

  

	 	(j)	headings are for ease of reference only and do not affect interpretation. 

 

	2.	Commencement and pre-conditions to employment 

  

	2.1	Commencement Date 

 The
Employee’s employment with the Company will commence on the Commencement Date and will continue until terminated in accordance with clause 2.2(b) or 11. 

  
 5. 

	2.2	 Probationary period 

  

	 	(a)	The Employee’s employment with the Company is subject to an initial three month probationary period (Probationary Period). 

 

	 	(b)	The Company may terminate the Employee’s employment at any time during the Probationary Period by providing the Employee, in writing, one week’s notice of
termination (or payment in lieu of such notice). 

  

	2.3	Warranty 

  

	 	(a)	The Employee represents and warrants to the Company that the entry into this agreement, and the performance of this agreement, by the Employee will not constitute a
breach of any contractual obligation, including any previous employment obligation, or of any relevant restraint, non-competition, confidentiality or intellectual property obligations, owed to any former employer. 

 

	 	(b)	The Employee indemnifies the Company and its officers against any Claim which the Company and its officers, pays or is liable for arising directly or indirectly from
the Employee breaching the warranty set out in clause 2.3(a). 

  

	3.	Position and duties 

  

	3.1	Position 

  

	 	(a)	The Company agrees to employ the Employee and the Employee will work for the Company: 

 

	 	(i)	in the Position at the Location; and 

  

	 	(ii)	in any additional or reasonably comparable substituted position directed by the Company and to which the Employee is appointed by the Company, after consultation with
the Employee. 

  

	 	(b)	For the avoidance of doubt, the terms and conditions set out in this agreement will continue to apply irrespective of any permitted change to the Position, unless
otherwise agreed in writing by the Company and the Employee. 

  

	3.2	Duties 

 The Employee must
perform the Employee’s duties consistent with the Position as assigned to the Employee from time to time by the Company to the best of the Employee’s ability and knowledge and in accordance with the highest standards of professionalism,
whether during or outside business hours. Without limitation, the Employee must 
  

	 	(a)	comply with all reasonable directions given to the Employee by the Company; 

 

	 	(b)	comply with all laws applicable to the Position in each of the jurisdictions in which the Group operates; 

 

	 	(c)	maintain professional awareness and development of skills and knowledge to ensure maintenance of best practice; 

 

	 	(d)	use all reasonable endeavours to safe guard the success, reputation and interests of the Group. 

  
 6. 

	3.3	 Company Policies 

  

	 	(a)	The Employee’s employment with the Company is subject to the Company’s rules and procedures set out in the Human Resources Manual. 

 

	 	(b)	It is the Employee’s responsibility to be thoroughly familiar with the contents of the Human Resources Manual, as varied and updated from time to time by the
Company. 

  

	 	(c)	In the event that any conflict exists between this agreement and the Human Resources Manual, this agreement prevails. 

 

	4.	Hours of Work 

  

	4.1	Hours 

  

	 	(a)	The Employee’s usual hours of work will be 38 hours per week, worked on Monday to Friday inclusive (Usual Hours). 

 

	 	(b)	The Employee will also be required to commit whatever reasonable additional hours (Additional Hours) are needed to properly manage and perform the
Employee’s duties and meet the reasonable requirements of the Position. 

  

	 	(c)	The Employee acknowledges that given the nature of the Position and the remuneration payable under this agreement the requirement to work Additional Hours is
reasonable. 

  

	4.2	Payment 

 The Employee
agrees and acknowledges that the Remuneration Package comprises compensation for Usual Hours and all and any Additional Hours worked by the Employee, and that the Employee is not entitled to payment of any amount in addition to the Remuneration
Package for any hours worked by the Employee outside the Usual Hours, unless discussed and agreed to by the company. 
  

	5.	Remuneration 

  

	5.1	Remuneration Package 

  

	 	(a)	The Employee will be entitled to receive a Remuneration Package comprising: 

 

	 	(i)	a base salary in the amount specified in item 4 of Schedule 1 (Base Salary); and 

 

	 	(ii)	other benefits specified in item 6 of Schedule 1. 

  

	 	(b)	The Remuneration Package is subject to the deduction or withholding of any amounts on account of any applicable taxation within the United States.

  

	5.2	Payment of Base Salary 

The Employee’s Base Salary will be paid monthly by direct deposit into a bank account of the Employee’s choice. 

 

	5.3	Superannuation 

 The
Remuneration Package is inclusive of superannuation, unless otherwise specified. 

  
 7. 

	5.4	 Remuneration review 

 The Company will review the Remuneration Package on an annual basis and the Company may alter the Employee’s total Remuneration Package and its components following that review. 

 

	5.5	Expenses 

  

	 	(a)	Subject to clause 5.5(b), the Company will pay for or reimburse the Employee for out of pocket expenses properly incurred by the Employee in connection with the
Employee’s employment, provided that the Employee provides the Company on request with a tax invoice substantiating each expense. 

  

	 	(b)	In the case of individual expenses exceeding the amount specified in item 7 of Schedule 1, the Employee must obtain the written approval of the Company in advance.

  

	5.6	Deductions 

 The Company
may deduct from the Base Salary or other sums due to the Employee any amount owned by the Employee on any account to the Group. 
  

	6.	Leave Entitlements 

  

	6.1	Annual Leave 

  

	 	(a)	The Employee is entitled to 20 days paid annual leave per year. 

  

	 	(b)	Annual leave will accrue on a pro-rata basis at the end of each completed four week period of continuous service with the Company and is cumulative.

  

	 	(c)	There is no entitlement to leave loading in respect to annual leave. 

  

	6.2	Personal/Carer’s Leave 

  

	 	(a)	The Employee is entitled to 10 days paid personal/carer’s leave per year. The Employee may use this personal/carer’s leave as sick leave or carer’s
leave. 

  

	 	(b)	Personal/carer’s leave will accrue on a pro rata basis at the end of each completed four week period of service with the Company and is cumulative.

  

	 	(c)	Accrued personal/carer’s leave will not form part of any benefit payable to the Employee on termination of the Employee’s employment.

  

	 	(d)	The Company may require the Employee to provide documentary evidence to support any personal/carer’s leave period. 

 

	6.3	Compassionate leave 

  

	 	(a)	The Employee is entitled to paid compassionate leave of up to five days for each occasion when a member of the Employee’s immediate family or a household member:

  

	 	(i)	contracts or develops a personal injury or illness that poses a serious threat to the Employee’s life; or 

 

	 	(ii)	dies. 

  
 8. 

	 	(b)	 Other special leave may be granted to the Employee in extenuating circumstances at the absolute discretion of the Company.

  

	6.4	 Parental Leave 

 The Employee will be entitled to parental leave in accordance with the applicable legislation in the Location. 
  

	6.5	 Long Service Leave 

 The Employee will be entitled to long service leave in accordance with the applicable legislation in the Location. 
  

	7.	 Conflicts of Interest 

  

	7.1	 Disclosure of interests 

 The Employee must declare to the Company the nature of any interests that the Employee may have directly or indirectly which might or might reasonably be expected to conflict with the Employee’s
duties to the Company. 
  

	7.2	 Restriction 

 The Employee must not engage in any work with products of a competitive nature to the company during the term of this agreement without the written consent of the Company and the Employee must not be
induced or agree to accept any commission, reward or benefit in connection with the Business from any person other than that which is provided under this agreement. 
  

	8.	 Confidential Information 

  

	8.1	 Prohibitions 

 The Employee must not without the Company’s prior written consent, either during the Employee’s employment with the Company or at any time after the termination of the Employee’s employment
with the Company: 
  

	 	(a)	 use for the Employee’s or another’s advantage any Confidential Information; 

 

	 	(b)	 disclose to any person any Confidential Information, either directly or indirectly; 

 

	 	(c)	 make copies of any Confidential Information; or 

  

	 	(d)	 counsel, procure or assist any person or corporation to use or disclose any Confidential Information, 

other than as reasonably required in the performance of the Employee’s duties as an employee of the Company or as
required by law. 
  

	8.2	 Protecting Unauthorised Use or Disclosure 

The Employee must use the Employee’s best endeavours to prevent the unauthorised use or disclosure of Confidential
Information by, or to, any third party. 

  
 9. 

	8.3	 Information already available to the public 

Clause 8.1 and 8.2 do not apply to information which is freely available to the public, other than as a result of a breach
by the Employee of this agreement. 
  

	8.4	 Survival 

 The obligations in this clause 8 survive termination of this agreement. 
  

	9.	 Intellectual Property 

  

	9.1	 Intellectual Property Rights 

 The Employee agrees that all Intellectual Property Rights created by the Employee during the course of, and in connection with, the Employee’s employment with the Company will immediately be
disclosed and assigned to, and vest in, the Company or such other person or company as may be nominated by the Company as such rights are created. 
  

	9.2	 Employee to assist 

 The Employee agrees to execute all documents and do all acts and things required by the Company for the purpose of vesting Intellectual Property Rights as prescribed by this clause 9, including without
limitation executing a deed of assignment of intellectual Property Rights in favour of the Company or its nominee. 
  

	9.3	 Royalties 

 The Employee acknowledges that all royalties, payments, fees, income or any other remuneration arising from Intellectual Property Rights are owned by the Company. 

 

	9.4	 Moral rights 

 To the extent permitted by law, the Employee waives all of the Employee’s moral rights in respect of any acts of the Company or any acts of third parties done with the Company’s authority in
relation to any Intellectual Property Rights that are the property of the Company and consent to the use, treatment, alteration and attribution of such Intellectual Property Rights as deemed appropriate by the Company. 

 

	9.5	 Survival 

 The obligations in this clause 9 survive termination of this agreement. 
  

	10.	 Restraint 

  

	10.1	 Clause 10 definitions 

 In this clause 10 (and any other provision of this agreement which relates to this clause or its subject matter), unless the context otherwise requires: 

 

	 	(a)	 Engage in means to participate, assist or otherwise be directly or indirectly involved in, including as a member, shareholder, unitholder,
director, consultant, adviser, contractor, principal, agent, manager, employee, beneficiary, partner, associate, trustee or financier; 

  

	 	(b)	 Restraint Area means the areas specified in item 8 of Schedule 1; 

  
 10.

	 	(c)	Restrained Business means a business or operation similar to, or competitive with, the Business; and 

 

	 	(d)	Restraint Period means the period specified in item 9 of Schedule 1. 

 

	10.2	Restraint obligations 

During the Restraint Period, the Employee must not, either directly, indirectly or as a result of contact by any other party, in the
Restraint Area, without the prior written consent of the Company (which it may withhold in its absolute discretion): 
  

	 	(a)	engage in a Restrained Business; 

  

	 	(b)	take any action to prepare to Engage in a Restrained Business; 

  

	 	(c)	be concerned or interested (directly or indirectly, or through any interposed body corporate, trust, principal, agent, shareholder, beneficiary, or as an independent
contractor or in any other capacity) in a Restrained Business; 

  

	 	(d)	solicit, canvas or secure the custom of any person who is, or was a customer, identified prospective customer, supplier, distributor or licensee of the Group with whom
the Employee dealt at any time during the last 12 months of the Employee’s employment with the Company for the purpose of transacting business relating to the Restrained Business; 

 

	 	(e)	accept any instructions to perform any work relating to the Restrained Business for any person who is, or was a customer, identified prospective customer, supplier,
distributor or licensee of the Group; or 

  

	 	(f)	induce or attempt to induce an employee or consultant of the Group to terminate their employment or consultancy with the Group. 

 

	10.3	Independence of restraints 

Each of the restraint obligations imposed by this clause 10 (which results from the combinations of Restraint Area, Restrained Business
and Restraint Period) is a separate and independent obligation from the other restraint obligations imposed (although they are cumulative in effect). 
  

	10.4	Reasonableness of restraint 

 The Employee acknowledges and agrees that each of the restraint obligations imposed by this clause 10 is reasonable in its extent (as to all of duration, geographical area and restrained conduct) having
regard to the interests of each party to this agreement and extends no further (in any respect) than is reasonably necessary and is solely to protect the Company’s legitimate interests. 

 

	10.5	Legal advice 

 Each party
acknowledges that in relation to this agreement and in particular this clause 10 it has received legal advice or has had the opportunity of obtaining legal advice. 
  

	10.6	Notification to prospective employer 

 The Employee must notify any prospective employer of the terms of the restrictions undertaken by him in this agreement. 

  
 11.

	10.7	Injunction 

 Each party to
this agreement acknowledges that monetary damages alone would not be adequate compensation to the Company for a breach of this clause 10 and that the Company is entitled to seek an injunction or other equitable relief from a Court of competent
jurisdiction if: 
  

	 	(a)	the Employee fails to comply or threatens to fail to comply with this clause 10; or 

 

	 	(b)	the Company has reason to believe the Employee will not comply with this clause 10. 

 

	10.8	Survival 

 The obligations
in this clause 10 survive termination of this agreement. 
  

	11.	Termination 

  

	11.1	General 

  

	 	(a)	Either party may terminate this agreement on the provision, in writing, of the period of written notice of termination specified in item 10 of Schedule 1 to the other
party. 

  

	 	(b)	The Company may terminate the Employee’s employment by making a payment of Base Salary plus superannuation contributions in lieu of notice of termination for all
or part of the notice period. 

  

	11.2	Termination without notice 

The Company may terminate the Employee’s employment without notice and without paying any amount in lieu of notice if the Employee:

  

	 	(a)	is guilty of serious misconduct or dishonesty; 

  

	 	(b)	commits any serious or persistent breach of any of the provisions of this agreement; 

 

	 	(c)	in the reasonable opinion of the Company, materially or persistently fails or neglects to perform or carry out the Employee’s duties under this agreement;

  

	 	(d)	refuses or neglects to comply with any lawful and reasonable order given to the Employee by the Company or any other person duly authorised by the Company;

  

	 	(e)	becomes bankrupt or suspends payment or compounds with or assigns the Employee’s estate for the benefit of the Employee’s creditors; 

 

	 	(f)	is continually and repeatedly absent from the Employee’s employment during normal working hours for reasons other than annual leave, leave arising from sickness or
disability or other absences that are approved by the Company; 

  

	 	(g)	has provided the Company with information about the Employee’s qualifications, experience, character or reputation which is misleading or was intended to be false
or misleading; 

  

	 	(h)	is incapacitated from performing the Employee’s duties for an aggregate period of three months in any period of 12 months; or 

  
 12.

	 	(i)	is convicted of any serious criminal offence which in the reasonable opinion of the Company might tend to injure the reputation or the Group or the Business.

  

	11.3	No redundancy 

 The
Employee acknowledges that the Employee will not be entitled to any redundancy payment that the Employee may otherwise be entitled to at law where the Employee’s employment is transferred to another employer, and qualifying service with the
Company, including recognised prior service, is recognised by the new employer for the calculation of all accrued entitlements, including in relation to any subsequent redundancy situation. 

 

	11.4	Employee’s obligations after termination 

 If the Employee’s employment is terminated for any reason: 
  

	 	(a)	the Company may set off any amounts the Employee owes the Company against any amounts the Company owes the Employee at the date of termination, except for amounts the
Company is not entitled by law to set off; and 

  

	 	(b)	the Employee must immediately return all property belonging to the Company, including all software, computers, credit cards, keys, security access passes, books,
vehicles and mobile phones. 

  

	12.	Personal information 

  

	12.1	Acknowledgement 

 The
Employee acknowledges that the Company will be required to request and hold personal information relating to the Employee for the purposes of administering the Employee’s employment. 

 

	12.2	Disclosure 

 The Employee
consents to the Company or any of its Related Companies disclosing personal information it holds regarding the Employee for purposes related to the Employee’s employment, and any other related purpose. 

 

	13.	General 

  

	13.1	Entire agreement 

 This
agreement constitutes the entire agreement between the parties in relation to its subject matter. All prior discussions, undertakings, agreements, representations, warranties and indemnities in relation to that subject matter are replaced by this
agreement and have no further effect. 
  

	13.2	No merger 

 The provisions
of this agreement will not merge on completion of any transaction contemplated in this agreement and, to the extent any provision has not been fulfilled, will remain in force. 

  
 13.

	13.3	 Attorneys 

 Each person who executes this agreement on behalf of a party under a power of attorney warrants that he or she has no notice of the revocation of that power or of any fact or circumstance that might
affect his or her authority to execute this agreement under that power. 
  

	13.4	 Amendment 

 This agreement may not be amended or varied unless the amendment or variation is in writing signed by all parties. 
  

	13.5	 Assignment 

 Neither party may assign, transfer or otherwise deal with this agreement or any right under this agreement without the prior written consent of each other party, which must not be unreasonably withheld.

  

	13.6	 Severability 

 Part or all of any provision of this agreement that is illegal or unenforceable will be severed from this agreement and will not affect the continued operation of the remaining provisions of this
agreement. 
  

	13.7	 Waiver 

 Waiver of any power or right under this agreement: 
  

	 	(a)	 must be in writing signed by the party entitled to the benefit of that power or right; and 

 

	 	(b)	 is effective only to the extent set out in that written waiver. 

 

	13.8	 Rights, remedies additional 

 Any rights and remedies that a person may have under this agreement are in addition to and do not replace or limit any other rights or remedies that the person may have. 

 

	13.9	 Further assurances 

 Each party must do or cause to be done all things necessary or reasonably desirable to give full effect to this agreement and the transactions contemplated by it (including, but not limited to, the
execution of documents). 
  

	13.10	 Costs 

 Except as specifically provided in this agreement, each party must bear its own legal, accounting and other costs for the preparation and execution of this agreement. 

 

	13.11	 Counterparts 

 This agreement may be executed in any number of counterparts and all counterparts taken together will constitute one document. 

  
 14.

	13.12	 Governing law and jurisdiction 

 This agreement will be governed by and construed in accordance with the laws in force in the State of New South Wales and each party submits to the non-exclusive jurisdiction of the courts of that State.

  
 15.

 Schedule 
 Details 
  

					
	 No.
	  	 Item
	  	 Description

	1.	  	Commencement Date	  	1st December 2009
			
	2.	  	Position	  	Clinical Affairs Director
			
	3.	  	Location	  	United States of America
			
	4.	  	Base Salary	  	US$175,000/year
			
	5.	  	Term	  	4 years
			
	6.	  	Other Benefits	  	The Company will:
			
		  		  	 (a)     subject to the Employee exceeding agreed performance targets determined by the Company in its
absolute discretion from time to time and all laws, on 1st December in second year and on the fourth year during the Employee’s employment with the Company grant the Employee 1,000,000 of Performance Options;

			
		  		  	 (b)     pay, or reimburse, the Employee for the cost of a comprehensive health insurance policy for the
Employee during the term of the Employee’s employment with the Company;

			
		  		  	For the purposes of this Schedule 1, Performance Option means an option entitling the holder to subscribe for one ordinary share in the Company, and having the terms specified in
Schedule 2.
			
	7.	  	Expense Limit	  	US$1000.00, exclusive of airline tickets
			
	8.	  	Restraint Area	  	N/A
			
	9.	  	Restraint Period	  	The period of the Employee’s employment with the Company and the period of six months’ from the cessation of the Employee’s employment with the
Company.
			
	10.	  	Termination notice period	  	Three months
			
	11.	  	Governing law and jurisdiction	  	New South Wales, Australia

  
 16.

 Schedule 2 
 Performance Options 
  

 

	1.	 Each Performance Option entitles the holder to subscribe for 1 fully paid ordinary share in the Company. 

 

	2.	 Vesting of the Performance Options is subject to the holder continuing to be an employee of the Company for not less than two years after the date
of grant of the Performance Options to the holder. 

  

	3.	 Despite any other paragraph of these terms, all Performance Options will immediately vest in the holder on the occurrence of either of the following
events: 

  

	 	(a)	 the offeror under a takeover bid or announcement acquires (unconditionally) in excess of 50% of the issued voting shares of the Company; or

  

	 	(b)	 as a result of the approval of one or more schemes of arrangement any person who is not at the date of issue of the options in control of the
Company acquires in excess of 50% of the issued voting shares of the Company. 

  

	4.	 Each Performance Option may be exercised at lesser of a price equal to ten cents(10) or the volume weighted average price of ordinary shares in the
Company traded on ASX during the 30 trading days immediately prior to the date of grant of the Performance Options to the holder at any time during the period commencing on the date the Performance Options vest pursuant to paragraph 2 or 3 of these
terms and ending at 5:00 pm (Sydney, NSW time) on the date two years following that date (Expiry Date) by completing the option exercise form and delivering it to the registered office of the Company. 

 

	5.	 Any Performance Option automatically lapses if: 

  

	 	(a)	 it has not been exercised prior to the Expiry Date; or 

 

	 	(b)	 the holder’s employment with the Company is terminated for any one or more of the following reasons: 

 

	 	(i)	 the holder is guilty of serious misconduct or dishonesty; 

 

	 	(ii)	 the holder commits any serious or persistent breach of any of the provisions of the holder’s employment agreement with the Company;

  

	 	(iii)	 in the reasonable opinion of the Company, the holder materially or persistently fails or neglects to perform or carry out the holder’s duties
under the holder’s employment agreement with the Company; 

  

	 	(iv)	 the holder refuses or neglects to comply with any lawful and reasonable order given to the holder by the Company or any other person duly authorised
by the Company; 

  

	 	(v)	 the holder becomes bankrupt or suspends payment or compounds with or assigns the holder’s estate for the benefit of the holder’s
creditors; 

  
 17.

	 	(vi)	 the holder is continually and repeatedly absent from the holder’s employment during normal working hours for reasons other than annual leave,
leave arising from sickness or disability or other absences that are approved by the Company; 

  

	 	(vii)	 the holder has provided the Company with information about the holder’s qualifications, experience, character or reputation which is misleading
or was intended to be false or misleading; or 

  

	 	(viii)	 the holder is convicted of any serious criminal offence. 

 

	6	 An exercise of only some Performance Options will not affect the rights of the holder under the balance of the Performance Options held by him or
her as appropriate. 

  

	7.	 The Company will not apply for official quotation by ASX of the Performance Options. 

 

	8.	 The Performance Options are non-transferable and may not be sold, assigned, transferred or otherwise dealt with in any way.

  

	9.	 Shares issued upon the exercise of Performance Options will rank pari passu with the Company’s fully paid ordinary shares and will have the
same voting and other rights as the existing shares of the Company, which are set out in the Company’s Constitution, ASX Listing Rules and the Corporations Act. 

 

	10.	 The Company will apply for official quotation by ASX of all shares issued upon exercise of Performance Options, subject to any restriction
obligations imposed by ASX. 

  

	11.	 The Performance Options will not give any right to participate in dividends until shares are issued pursuant to the exercise of the relevant
Performance Options. 

  

	12.	 There are no participation rights or entitlements inherent in the Performance Options and holders will not be entitled to participate in new issues
of capital offered to shareholders during the currency of the Performance Options. 

  

	13.	 In the event of any reconstruction (including consolidation, subdivision, reduction or return) of the issued capital of the Company prior to the
Expiry Date, the number of Performance Options or the rights attaching to the Performance Options or both shall be reconstructed in accordance with the ASX Listing Rules applying to a reorganisation of capital at the time of the reconstruction.

  
 18.

									
	 EXECUTED as an agreement
	 		 		 		  	
					
	 EXECUTED by PRIMA BIOMED
	 	 )
	 		 		  	
	 LIMITED ACN 009 237 889 in
	 	 )
	 		 		  	
	 accordance with section 127 of the
	 	 )
	 		 		  	
	 Corporations Act 2001
	 	 )
	 		 		  	
		 	 )
	 		 		  	
			
	 /s/ Martin Rogers
	 		 	 /s/ Ata Gokyildirim

	 Signature of Director
	 		 		 	 Signature of Director/Secretary

			
	 Martin Rogers
	 		 	 Ata Gokyildirim

	 Name of Director
	 		 		 	 Name of Director/Secretary

					
	 SIGNED by GINNY RAYMOND
	 	 )
	 		 		  	
	 in the presence of:
	 	 )
	 		 		  	
		 	 )
	 		 		  	
		 	 )
	 		 		  	
		 	 )
	 		 		  	
			
	 /s/ Sydney Welt
	 		 	 /s/ Ginny Raymond

	 Signature of Witness
	 		 		 	 Ginny Raymond

				
	 Sydney Welt
	 		 		  	
	 Name of Witness
	 		 		 		  	

  
 19.Employment Agreement

 Exhibit 4.14 
 Consulting Agreement 
 This Agreement (“Agreement”) is by and
between Prima Biomed USA Inc., including its affiliates and subsidiaries, having its principal office at 415 East 37th Street, Suite 7D, New York, NY 10016 (hereinafter collectively referred to as Company) and Sharron Gargosky, PhD, at 2833 NW
Cumberland Rd, Portland, OR 97210 (hereinafter referred to as Consultant). 
 In consideration of the mutual covenants as set
forth below, the parties named above agree as follows: 
  

	1.	 SERVICES The services to be performed by Consultant (“Services”) involve 

 

	 	•	 	 Assisting in the strategic planning of CVacTM development, as well as management of related scientific, nonclinical, clinical, and regulatory issues;

  

	 	•	 	 Providing information and independent opinions to the Company with regards to CVacTM and other products under development; and 

 

	 	•	 	 Other services as requested by the Company 

These Services will be provided by Sharron Gargosky, PhD. 

 

	2.	 COMPENSATION The compensation to be paid to Consultant for performance of the Services described above will be based on actual hours worked
on the project. The billing rate is $175 per hour for regular working time and 50% thereof for travel time (including air, rail, and auto travel to and from any place not the Consultant’s regular place of work). Consultant shall be reimbursed
upon receipt of an invoice for all reasonable travel, lodging, and meal expenses, and all reasonable expenses incidental to travel and other’ expenses specific to the Services provided. Consultant shall receive prior approval from Company prior
to incurring incidental expenses exceeding $500; the Company reserves the right not to reimburse costs exceeding $500 if prior approval was not been granted. Invoices will be provided to Company on a monthly basis and will identify work performed
for the invoice month according to Company’s standard hour tracking. Payment will be due within 30 days of invoice date. Consultant will charge a late payment fee of 1 1/2% per month, or the maximum amount permitted by law if less
than 1 1/2% per month, for any payment not received
within 30 days from invoice date. If a portion of an invoice is in dispute, then Company shall pay the undisputed amounts as set forth in the preceding sentence and the parties shall use good faith efforts to reconcile the disputed amount within
(60) days invoice date. 

  

	3.	 RIGHTS TO DEVELOPMENT All work product developed by Consultant in the performance of Services including, but not limited to, papers, records,
reports, analyses, computer based information and drawings (collectively “Developments”) and the patentable intellectual property rights in any such material will be the sole and exclusive property of Company provided, however, that
Consultant shall retain the sole and exclusive right to any procedural manuals, personnel data, computer software, processes, process technology, means and know-how developed by Consultant independently from Consultant’s Services provided under
this Agreement. 

  

	4.	 CONFIDENTIAL INFORMATION In order to facilitate Consultant’s Services under this Agreement, it may be necessary for Company to disclose
certain data and other proprietary information to Consultant that will, if possible, be labeled with the text “confidential”, and/or to provide Consultant with samples, which, together with any information generated by Consultant in
performing Consultant’s Services for Company hereunder (collectively “Technology”). Consultant agrees to retain in strict confidence and not to disclose or transfer any Technology denoted as confidential to any party other than as
authorized by Company. Consultant further agrees not to use such information for any purposes other than those of this Agreement. Upon completion of Consultant’s Services hereunder, Consultant will return all Technology copies and any remaining
samples to Company, upon request by Company. These obligations of confidentiality and non-use shall not apply to technology: a) that was previously known to Consultant as evidenced by Consultant’s written records, b) that is lawfully obtained
by Consultant from a source independent 

  
  

 
 Page 1 

	 	 
of Company, c) that is now or becomes public knowledge other than by breach of this Agreement, or d) is otherwise required to be disclosed by law. 

All information regarding Consultant’s pricing and Consultant’s procedural manuals, data, computer software,
processes, process technology, means and know-how developed by Consultant and disclosed by Consultant to Company in connection with this Agreement is proprietary, confidential information (“Consultant Know-How”) belonging to Consultant.
Consultant Know-How will be held confidential by Company. 
  

	5.	 TERM AND TERMINATION This Agreement will commence on 5 July 2010 and remains in full force and effect until 31 December 2010,
unless mutually extended or terminated early. This Agreement may be terminated by either party, at any time, upon 30-days advance written notice to the other party. Upon the termination of this Agreement, each party will be released from all
obligations and liabilities to the other occurring or arising after the date of termination, except that such termination will not relieve either party of its obligations under Paragraph 4 above, for a period of five (5) years from termination
of this Agreement or from liability arising from any breach of this Agreement. The obligations under Paragraph 12 shall survive the expiration or termination of this Agreement for a period of five (5) years. 

 

	6.	 ASSIGNMENT The rights and liabilities of the parties will bind and inure to the benefit of their respective successors, heirs, executors and
administrators, as the case may be, provided that Company has specifically contracted for Consultant’s services. Consultant may not assign or delegate its obligations under this Agreement either in whole or in part without the prior written
consent of Company. 

  

	7.	 GOVERNING LAW: SEVERABILITY This Agreement will be governed by the laws of the State of New York without reference to any conflict of law
provision. The parties hereby consent to the jurisdiction of the New York courts for resolution of any disputes arising under this Agreement. If any provision of this Agreement is found by a court of competent jurisdiction to be unenforceable, that
provision will be severed and the remainder of this Agreement will continue in full force and effect. 

  

	8.	 COMPLETE UNDERSTANDING: MODIFICATION Except as expressly provided herein, this Agreement will supersede and render null and void any and all
prior Agreements between the parties and their agents and personnel on the subject of this Agreement. Any modifications to the provisions herein must be in writing and signed by the parties. 

 

	9.	 NOTICES Any notices required or permitted hereunder will be given in writing to the appropriate party at the address specified below or at
such address as the party will specify. Such notice will be deemed given upon personal delivery to the appropriate address or sent by certified or registered mail, three days after the date of mailing. 

 

	10.	 FORCE MAJEURE No party shall be liable for the delay in performance or failure to perform this Agreement if such delay or failure is due to
any occurrence beyond the control of the parties including, without limitation, fire, explosion, weather, disease, war, insurrection, civil strife, riots, government action or power failure; provided, however, that the party who is unable to perform
resumes performance as soon as possible following the end of the occurrence causing delay or failure. 

  

	11.	 WAIVER The waiver of either party or the failure by either party to claim a breach of any provision of this Agreement shall not be deemed to
constitute a waiver or estoppel with respect to any subsequent breach or with respect to any provision thereof. 

  

	12.	 INDEMNITY Company hereby agrees to indemnify, defend, and hold Consultant harmless from and against any and all loss, claims, actions,
liability and/or suits (including reasonable attorney’s 

  
  

 
 Page 2 

	 	 
fees) arising directly or indirectly as a result of this Agreement except to the extent that any such loss, cost, claims, actions, liability and/or suits is directly caused by the gross
negligence or intentional misconduct of Consultant in the performance of the Services under this Agreement. 

 Consultant hereby agrees to indemnify, defend, and hold Company, its employees, officers, directors and principals harmless from and against any and all loss, claims, actions, liability and/or suits
(including reasonable attorney’s fees) arising directly as a result of the gross negligence or intentional misconduct of Consultant in the performance of its Services under this Agreement except to the extent that any such loss, cost, claims,
actions, liability and/or suits is directly caused by the gross negligence or intentional misconduct of Company, its employees, officers, directors and principals. 
  

	13.	 DAMAGES In the event of any breach or default by either party with respect to this Agreement, the defaulting party’s damage liability to
the non-defaulting party for such breach or default shall be limited to the non-defaulting party’s direct damages which shall not exceed the fees paid by Company to Consultant under this Agreement. Under no circumstances will either party be
liable for any consequential, special or indirect damages for the breach of its obligations under this Agreement 

  

	14.	 NON-COMPETITION Without prior consent of the Company, during the term of this Agreement, Consultant agrees not to consult with, provide
services to, or assist (actively or otherwise), whether paid or unpaid, any Direct Competitor of Prima BioMed USA Inc., or its Affiliates. For purposes of this Agreement, a Direct Competitor means any person, group, or company researching and/or
developing cell therapeutics or immunological medicinal products intended for the treatment or prevention of cancer. 

  

	15.	 INDEPENDENT CONTRACTOR For the purposes of this Agreement, the parties hereto are independent contractors and nothing contained in this
Agreement shall be construed to place them in the relationship of partners, principal and agent, employer/employee or joint ventures. Neither party shall have the power or right to bind or obligate the other party, nor shall it hold itself out as
having such authority. 

 The parties hereto have executed this Agreement as of the last date signed below.

  

					
	Prima BioMed USA Inc.
			
	By:	 	 /s/ Matthew Lehman
	 	(signature)
	Name:	 	Matthew Lehman	 	
	Title:	 	Chief Operating Officer	 	
	Date:	 	20 July 2010	 	

 Consultant: 
  

					
	 By:
	 	 /s/ Sharron Gargosky
	 	 (signature)

	 Name:
	 	 Sharron Gargosky, PhD
	 	
	 Title:
	 	 Member
	 	
	 Date:
	 	 20 July 2010
	 	

  
  

 
 Page 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00199-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00199-of-00352.parquet"}]]